Skip to content

Study of the Breast Milk Microbiota and Its Influence on the Development of Early and Late Neonatal Bacterial Sepsis Under Three Months of Age.

Exploration of Breast Milk by Culture Through Microbial Culturomics and by Targeted Metagenomics Through 16S Ribosomal RNA Gene Sequencing. Influence on the Development of Early and Late Neonatal Sepsis in Infants Under Three Months of Age.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05490498
Acronym
MINEOS
Enrollment
75
Registered
2022-08-05
Start date
2022-07-13
Completion date
2024-12-12
Last updated
2022-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Sepsis

Brief summary

Breast milk contains many microorganisms including bacteria that are beneficial to health (probiotics), but also bacteria that are generally considered pathogenic. Several studies have described an increased risk of infections due to pathogenic germs in breast milk in premature newborns whose digestive system is immature and whose digestive flora is modified by repeated antibiotic treatments. However, a breastfed baby is better protected against infectious diseases than a bottle-fed baby. The objective of this study is to define the breast milk microbiota of infants with confirmed early or late neonatal bacterial infection compared to the breast milk microbiota of infants with no evidence of bacterial infection. For that purpose, an exploration will be performed using the principle of Microbial Culturomics and targeted metagenomics (16S ribosomal RNA gene sequencing).

Interventions

OTHERCollection of breast milk

Collection of breast milk through a sterilized breastfeeding device. Once the collection is completed, the milk will be transferred to a sterile jar provided in a dedicated survey package for transport to the laboratory.

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

Breastfeeding mothers of infants: * Aged 1 to 89 days consulting in hospitals in the Marseille area (Assistance Publique des Hôpitaux de Marseille: Hôpital de la Timone-enfants and Hôpital Nord), * Suspected neonatal bacterial infection due to the presence of fever (rectal or axillary temperature \> 38°C), * In whom bacteriological samples have been taken (cerebrospinal fluid, joint fluid, blood cultures, urine), * Patients affiliated or benefiting from a social security system.

Exclusion criteria

* Exclusive formula milk feeding * Opposition of legal guardians * No bacteriological sample to prove infant infection * No confirmation of fever by standardized method * Opposition to participating in the study * Neonatal hospitalization \> 48 hours for management of prematurity. * Severe congenital malformations in the infant. * Antibiotic treatment for a concomitant bacterial infection in the infant.

Design outcomes

Primary

MeasureTime frameDescription
Description of bacterial carriage of breast milk18 monthsIdentify the bacterial carriage of breast milk of infants with neonatal sepsis. Microbial anlaysis of mother's milk from baby with neonatal sepsis.

Secondary

MeasureTime frameDescription
Comparison of breast milk of infants with neonatal sepsis to infants without neonatal sepsis.18 monthsCompare the bacterial carriage (type of germs found) of the breast milk of infants with neonatal sepsis to breast milk of infants with fever for another cause (virus, non identified germ)
Comparison of milk germs to children's germs.18 monthsCompare the germs found in the breast milk of each mother-infant pair with a bacterial infection with the germs identified in the infant.
Comparison of microbiota profiles in breast milk18 monthsCompare the bacterial composition of the breast milk of mother-infant pairs with the same germ (germ infecting the child identical to the germ identified in the mother's milk) versus mother-infant pairs with a different germ in the milk (no germ found in the child when a germ was identified in the breast milk, or germ infecting the child different from the germ identified in the mother's milk).

Countries

France

Contacts

Primary ContactLucile LESAGE
Lucile.LESAGE@ap-hm.fr0491386817

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026